After the FDA approved both combination macitentan/tadalafil (Opsynvi) and the biologic therapy sotatercept (Winrevair) for ...

Ralinepag XR is under clinical development by United Therapeutics and currently in Phase III for Pulmonary Arterial Hypertension.

Increasing average concentrations of sotatercept improved 6-minute walk distance, pulmonary vascular resistance, and levels of NT-proBNP.

The top articles about pulmonary arterial hypertension (PAH) in 2024 included FDA approvals, the effect of salt substitutes ...

Treprostinil is under clinical development by United Therapeutics and currently in Phase III for Idiopathic Pulmonary Fibrosis.

District Headquarters at Lakshadweep Islands received a request for urgent medical evacuation of a patient from the UTL ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Patients with pulmonary arterial hypertension and cardiovascular comorbidities may benefit from the use of inhaled or oral ...

PAH, or pulmonary hypertension, can leave someone breathless even after a short walk, but better drug combinations have ...

Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has introduced a groundbreaking medication for ...

INR:4330. 2019 cricket world cup Zhengda Tianqing's first generic version of pulmonary arterial hypertension drug "Macitentan Tablets" is about to be appro ...